{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:23:04Z","timestamp":1776709384075,"version":"3.51.2"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), new variants with enhanced transmissibility and pathogenicity have surfaced. The World Health Organization has designated five such variants\u2014Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529)\u2014as variants of concern. Each variant exhibits distinct characteristics, with many displaying a combination of point mutations and insertions\/deletions (indels). These genetic alterations, including mutations, recombinations, and rearrangements, contribute to the emergence of new strains that may exhibit modified phenotypes. However, identifying recombinant forms can be challenging due to their resemblance to other lineages. It is critical to monitor the evolution of new recombinant variants, particularly in light of the potential for vaccine-resistant strains and their accelerated propagation. Recombination has played a pivotal role in the development of certain SARS-CoV-2 variants, such as XA, XD, XF, XE, and XBB, among others. This report delves into the significance of recombination in the evolution of SARS-CoV-2 variants, especially Omicron sublineages, underscoring the necessity for continuous surveillance of the SARS-CoV-2 genome to identify newly emerged recombinant variants.<\/jats:p>","DOI":"10.1093\/lambio\/ovae074","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:37:25Z","timestamp":1722472645000},"source":"Crossref","is-referenced-by-count":5,"title":["The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB"],"prefix":"10.1093","volume":"77","author":[{"given":"Bardia","family":"Karim","sequence":"first","affiliation":[{"name":"Student Research Committee, Babol University of Medical Sciences , Babol 4717647745 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Barary","sequence":"additional","affiliation":[{"name":"Student Research Committee, Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences , Tehran 1983969411 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Fereydouni","sequence":"additional","affiliation":[{"name":"COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran , Pasteur Ave., Tehran 1316943551 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Sanjari","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Pharmacy, Islamic Azad University, Ayatollah Amoli Branch , Amol 678 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezvan","family":"Hosseinzadeh","sequence":"additional","affiliation":[{"name":"Student Research Committee, Babol University of Medical Sciences , Babol 4717647745 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Salehi-Vaziri","sequence":"additional","affiliation":[{"name":"Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran , Pasteur Ave., Tehran 01316943551 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Maleki","sequence":"additional","affiliation":[{"name":"COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran , Pasteur Ave., Tehran 1316943551 , Iran"},{"name":"Department of Influenza and Respiratory Viruses, Pasteur Institute of Iran , Pasteur Ave., Tehran 1316943551 , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"2024091807514183600_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2106\/JBJS.20.00557","article-title":"Economic impacts of the COVID-19 crisis: an orthopaedic perspective","volume":"102","author":"Anoushiravani","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"2024091807514183600_bib2","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41423-021-00779-5","article-title":"The spike protein of SARS-CoV-2 variant a.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency","volume":"18","author":"Arora","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2024091807514183600_bib3","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.celrep.2021.109825","article-title":"B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination","volume":"37","author":"Arora","year":"2021","journal-title":"Cell Rep"},{"key":"2024091807514183600_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1473-3099(22)00224-9","article-title":"Comparable neutralisation evasion of SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.3","volume":"22","author":"Arora","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024091807514183600_bib4","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.3390\/ijms232214057","article-title":"The SARS-CoV-2 Delta\u2013Omicron recombinant lineage (XD) exhibits immune-escape properties similar to the Omicron (BA.1) variant","volume":"23","author":"Arora","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024091807514183600_bib6","first-page":"423","article-title":"A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa","volume-title":"Science","author":"Autoria","year":"2021"},{"key":"2024091807514183600_bib7","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1038\/s41467-022-33910-9","article-title":"Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France","volume":"13","author":"Bal","year":"2022","journal-title":"Nat Commun"},{"key":"2024091807514183600_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"2024091807514183600_bib9","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J Clin Invest"},{"key":"2024091807514183600_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.medj.2022.10.002","article-title":"Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination","volume":"3","author":"Bolze","year":"2022","journal-title":"Med"},{"key":"2024091807514183600_bib11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.medj.2022.10.002","article-title":"Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination","volume":"3","author":"Bolze","year":"2022","journal-title":"Med"},{"key":"2024091807514183600_bib12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat Microbiol"},{"key":"2024091807514183600_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41564-021-00933-9","article-title":"A SARS-CoV-2 lineage a variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic","volume":"6","author":"Bugembe","year":"2021","journal-title":"Nat Microbiol"},{"key":"2024091807514183600_bib14","doi-asserted-by":"crossref","first-page":"106670","DOI":"10.1016\/j.ijsu.2022.106670","article-title":"Recombinant SARS-CoV-2 variants XD, XE, AND XF: the emergence of recombinant variants requires an urgent call for research\u2014correspondence","volume":"102","author":"Chakraborty","year":"2022","journal-title":"Int J Surg"},{"key":"2024091807514183600_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41588-022-01033-y","article-title":"Global landscape of SARS-CoV-2 genomic surveillance and data sharing","volume":"54","author":"Chen","year":"2022","journal-title":"Nat Genet"},{"key":"2024091807514183600_bib16","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","volume":"27","author":"Choi","year":"2021","journal-title":"Nat Med"},{"key":"2024091807514183600_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.15585\/mmwr.mm7117e3","article-title":"Seroprevalence of infection-induced SARS-CoV-2 antibodies\u2014United States, september 2021\u2013february 2022","volume":"71","author":"Clarke","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024091807514183600_bib18","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/jmv.27789","article-title":"Culture and identification of a \u201cDeltamicron\u201d SARS-CoV-2 in a three cases cluster in southern France","volume":"94","author":"Colson","year":"2022","journal-title":"J Med Virol"},{"key":"2024091807514183600_bib19","first-page":"000751","article-title":"Unusual SARS-CoV-2 intrahost diversity reveals lineage superinfection","volume":"8","author":"Dezordi","year":"2022","journal-title":"Microb Genom"},{"key":"2024091807514183600_bib20","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1007\/s11356-021-14429-w","article-title":"The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment","volume":"28","author":"Dhama","year":"2021","journal-title":"Environ Sci Pollut Res"},{"key":"2024091807514183600_bib21","doi-asserted-by":"crossref","first-page":"113522","DOI":"10.1016\/j.biopha.2022.113522","article-title":"Omicron variant (B.1.1.529) and its sublineages: what do we know so far amid the emergence of recombinant variants of SARS-CoV-2?","volume":"154","author":"Dhawan","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2024091807514183600_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2024091807514183600_bib23","article-title":"Delta\u2013Omicron recombinant SARS-CoV-2 in a transplant patient treated with sotrovimab","author":"Duerr","year":"2022","journal-title":"bioRxiv"},{"key":"2024091807514183600_bib24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMc2205019","article-title":"Neutralization of the SARS-CoV-2 Deltacron and BA.3 variants","volume":"16","author":"Evans","year":"2022","journal-title":"N Engl J Med"},{"key":"2024091807514183600_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12985-022-01887-y","article-title":"As the virus evolves, so too must we: a drug developer\u2019s perspective : we need a new paradigm in searching for next-generation countermeasures","volume":"19","author":"Fang","year":"2022","journal-title":"Virol J"},{"key":"2024091807514183600_bib26","article-title":"Comprehensive fitness landscape of SARS-CoV-2 mpro reveals insights into viral resistance mechanisms","author":"Flynn","year":"2022","journal-title":"bioRxiv"},{"key":"2024091807514183600_bib27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/v14061239","article-title":"Recombination in coronaviruses, with a focus on SARS-CoV-2","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"key":"2024091807514183600_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.chom.2022.06.010","article-title":"Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in north America","volume":"30","author":"Gutierrez","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2024091807514183600_bib29","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S1473-3099(23)00746-6","article-title":"Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study","volume":"24","author":"Hansen","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2024091807514183600_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mco2.110","article-title":"SARS-CoV-2 Omicron variant: characteristics and prevention","volume":"2","author":"He","year":"2021","journal-title":"MedComm"},{"key":"2024091807514183600_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"2024091807514183600_bib32","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/JVI.01926-07","article-title":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus","volume":"82","author":"Hon","year":"2008","journal-title":"J Virol"},{"key":"2024091807514183600_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/bib\/bbaa386","article-title":"Bioinformatics resources for SARS-CoV-2 discovery and surveillance","volume":"22","author":"Hu","year":"2021","journal-title":"Brief Bioinform"},{"key":"2024091807514183600_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"2024091807514183600_bib35","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.cell.2021.08.014","article-title":"Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic","volume":"184","author":"Jackson","year":"2021","journal-title":"Cell"},{"key":"2024091807514183600_bib36","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1002\/jmv.27936","article-title":"Molecular aspects of Omicron, vaccine development, and recombinant strain XE: a review","volume":"94","author":"K","year":"2022","journal-title":"J Med Virol"},{"key":"2024091807514183600_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1099\/jgv.0.001439","article-title":"The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection","volume":"101","author":"Kellam","year":"2020","journal-title":"J Gen Virol"},{"key":"2024091807514183600_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/vaccines8020220","article-title":"A novel synonymous mutation of SARS-CoV-2: is this possible to affect their antigenicity and immunogenicity?","volume":"8","author":"Kim","year":"2020","journal-title":"Vaccines"},{"key":"2024091807514183600_bib39","doi-asserted-by":"crossref","first-page":"859900","DOI":"10.3389\/fpubh.2022.859900","article-title":"Evidence for recombination as an evolutionary mechanism in coronaviruses: is SARS-CoV-2 an exception?","volume":"10","author":"Kozlakidis","year":"2022","journal-title":"Front Public Health"},{"key":"2024091807514183600_bib40","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1080\/22221751.2022.2099305","article-title":"Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection","volume":"11","author":"Kurhade","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2024091807514183600_bib41","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3201\/eid2807.220526","article-title":"SARS-CoV-2 Delta\u2013Omicron recombinant viruses, United States","volume":"28","author":"Lacek","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024091807514183600_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60286-9","article-title":"The molecular biology of coronaviruses","volume":"48","author":"Lai","year":"1997","journal-title":"Adv Virus Res"},{"key":"2024091807514183600_bib43","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-022-01887-z","article-title":"Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1\/BA.1.1 or BA.2 subvariant infection in southern California","volume":"28","author":"Lewnard","year":"2022","journal-title":"Nat Med"},{"key":"2024091807514183600_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm7304a2","article-title":"Early estimates of updated 2023\u20132024 (Monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults\u2014increasing community access to testing program, United States, September 2023\u2013January 2024","volume":"73","author":"Link-Gelles","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024091807514183600_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/v11110979","article-title":"Viral metagenomics revealed sendai virus and coronavirus infection of Malayan Pangolins (Manis javanica)","volume":"11","author":"Liu","year":"2019","journal-title":"Viruses"},{"key":"2024091807514183600_bib45","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 (preprint)","volume-title":"bioRxiv","author":"Liu","year":"2021"},{"key":"2024091807514183600_bib47","first-page":"1","article-title":"Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"key":"2024091807514183600_bib48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.15585\/mmwr.mm7208a4","article-title":"Notes from the field: epidemiologic characteristics of SARS-CoV-2 recombinant variant XBB. 1.5\u2014New York city, November 1, 2022\u2013January 4, 2023","volume":"72","author":"Luoma","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024091807514183600_bib49","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3390\/v3091699","article-title":"Recombination in eukaryotic single stranded DNA viruses","volume":"3","author":"Martin","year":"2011","journal-title":"Viruses"},{"key":"2024091807514183600_bib50","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1002\/jmv.27780","article-title":"The recombinant variants of SARS-CoV-2: concerns continues amid COVID-19 pandemic","volume":"94","author":"Mohapatra","year":"2022","journal-title":"J Med Virol"},{"key":"2024091807514183600_bib51","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/jmv.27585","article-title":"Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: a challenging global threat with a special focus on the Indian subcontinent","volume":"94","author":"Mohapatra","year":"2022","journal-title":"J Med Virol"},{"key":"2024091807514183600_bib66","first-page":"veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume-title":"Virus Evol","author":"O\u2019Toole","year":"2021"},{"key":"2024091807514183600_bib54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrg3908","article-title":"Genetic linkage analysis in the age of whole-genome sequencing","volume":"16","author":"Ott","year":"2015","journal-title":"Nat Rev Genet"},{"key":"2024091807514183600_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-022-00992-2","article-title":"Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events","volume":"7","author":"Ou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2024091807514183600_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-30884-6","article-title":"Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine","volume":"13","author":"Patalon","year":"2022","journal-title":"Nat Commun"},{"key":"2024091807514183600_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/microorganisms9020300","article-title":"Dynamics of a dual SARS-CoV-2 lineage co-infection on a prolonged viral shedding COVID-19 case: insights into clinical severity and disease duration","volume":"9","author":"Pedro","year":"2021","journal-title":"Microorganisms"},{"key":"2024091807514183600_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.meegid.2014.12.022","article-title":"Recombination in viruses: mechanisms, methods of study, and evolutionary consequences","volume":"30","author":"Perez-Losada","year":"2015","journal-title":"Infect Genet Evol"},{"key":"2024091807514183600_bib59","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2024091807514183600_bib60","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s42770-022-00848-5","article-title":"SARS-CoV-2 Omicron BA.1, BA.2, and XAG identification during routine surveillance on a university campus in Belo Horizonte, Brazil, 2022","volume":"53","author":"Queiroz","year":"2022","journal-title":"Braz J Microbiol"},{"key":"2024091807514183600_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.virol.2020.12.018","article-title":"Potential apobec-mediated rna editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution","volume":"556","author":"Ratcliff","year":"2021","journal-title":"Virology"},{"key":"2024091807514183600_bib62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/pathogens9030240","article-title":"Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2","volume":"9","author":"Rehman","year":"2020","journal-title":"Pathogens"},{"key":"2024091807514183600_bib63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"2024091807514183600_bib64","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.meegid.2011.04.031","article-title":"Molecular evolution of human species D adenoviruses","volume":"11","author":"Robinson","year":"2011","journal-title":"Infect Genet Evol"},{"key":"2024091807514183600_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00705-021-05295-5","article-title":"Evolution of the SARS-CoV-2 genome and emergence of variants of concern","volume":"167","author":"Safari","year":"2022","journal-title":"Arch Virol"},{"key":"2024091807514183600_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41591-022-02092-8","article-title":"Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice","volume":"29","author":"Scheaffer","year":"2022","journal-title":"Nat Med"},{"key":"2024091807514183600_bib68","doi-asserted-by":"crossref","first-page":"e2381","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 Omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev Med Virol"},{"key":"2024091807514183600_bib69","doi-asserted-by":"crossref","first-page":"1008600","DOI":"10.3389\/fmed.2022.1008600","article-title":"Molecular characterization of a new SARS-CoV-2 recombinant cluster XAG identified in Brazil","volume":"9","author":"Silva","year":"2022","journal-title":"Front Med"},{"key":"2024091807514183600_bib70","first-page":"1","article-title":"Mosaic recombination inflicted various SARS-CoV-2 lineages to emerge into novel virus variants: a review update","volume":"38","author":"Singh","year":"2022","journal-title":"Indian J Clin Biochem"},{"key":"2024091807514183600_bib71","doi-asserted-by":"crossref","first-page":"6307457","DOI":"10.1155\/2020\/6307457","article-title":"Potential of plant bioactive compounds as SARS-CoV-2 main protease (mpro) and spike (s) glycoprotein inhibitors: a molecular docking study","volume":"2020","author":"Tallei","year":"2020","journal-title":"Scientifica"},{"key":"2024091807514183600_bib72","doi-asserted-by":"crossref","first-page":"e66857","DOI":"10.7554\/eLife.66857","article-title":"Patterns of within-host genetic diversity in SARS-CoV-2","volume":"10","author":"Tonkin-Hill","year":"2021","journal-title":"eLife"},{"key":"2024091807514183600_bib73","article-title":"Covid data tracker","author":"Trends","year":"2021"},{"key":"2024091807514183600_bib74","doi-asserted-by":"crossref","first-page":"iyab074","DOI":"10.1093\/genetics\/iyab074","article-title":"Rapid detection of inter-clade recombination in SARS-CoV-2 with bolotie","volume":"218","author":"Varabyou","year":"2021","journal-title":"Genetics"},{"key":"2024091807514183600_bib76","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2024091807514183600_bib75","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1002\/jmv.27939","article-title":"Potential intervariant and intravariant recombination of Delta and Omicron variants","volume":"94","author":"Wang","year":"2022","journal-title":"J Med Virol"},{"key":"2024091807514183600_bib77","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"2024091807514183600_bib78","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.chom.2022.09.002","article-title":"Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75","volume":"30","author":"Wang","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2024091807514183600_bib79","first-page":"279","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"19","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"2024091807514183600_bib80","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1002\/ctm2.680","article-title":"How to translate the knowledge of COVID-19 into the prevention of Omicron variants","volume":"11","author":"Wang","year":"2021","journal-title":"Clin Transl Med"},{"key":"2024091807514183600_bib81","doi-asserted-by":"crossref","first-page":"e61312","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"eLife"},{"key":"2024091807514183600_bib52","article-title":"Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern","author":"World Health Organization: WHO","year":"2021"},{"key":"2024091807514183600_bib53","article-title":"Tracking SARS-CoV-2 variants","author":"World Health Organization: WHO","year":"2022"},{"key":"2024091807514183600_bib82","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications","author":"Wu","year":"2020","journal-title":"MedRxiv"},{"key":"2024091807514183600_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2024091807514183600_bib84","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1039\/D1NR01672E","article-title":"Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study","volume":"13","author":"Yang","year":"2021","journal-title":"Nanoscale"},{"key":"2024091807514183600_bib85","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/ciaa219","article-title":"2019 novel coronavirus is undergoing active recombination","volume":"71","author":"Yi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024091807514183600_bib86","article-title":"Enhanced transmissibility of XBB. 1.5 is contributed by both strong ACE2 binding and antibody evasion","author":"Yue","year":"2023","journal-title":"Biorxiv"},{"key":"2024091807514183600_bib87","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/j.csbj.2022.07.042","article-title":"Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages","volume":"20","author":"Zhou","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"2024091807514183600_bib88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Letters in Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lambio\/advance-article-pdf\/doi\/10.1093\/lambio\/ovae074\/58696336\/ovae074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/8\/ovae074\/59175666\/ovae074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/8\/ovae074\/59175666\/ovae074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T07:52:18Z","timestamp":1726645938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lambio\/article\/doi\/10.1093\/lambio\/ovae074\/7724385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":88,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/lambio\/ovae074","relation":{},"ISSN":["1472-765X"],"issn-type":[{"value":"1472-765X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,30]]},"article-number":"ovae074"}}